Ulobetasol

Ulobetasol

Ulobetasol

Chemical compound

Ulobetasol (INN) or halobetasol (USAN) is a corticosteroid used to treat psoriasis.[1][2] It is a class I corticosteroid under the US classification and a group III corticosteroid under international classification, the most potent group of such drugs.[3][4]

Quick Facts Clinical data, Trade names ...

Ulobetasol propionate is usually supplied as a 0.05% topical cream.[1] Ulobetasol is the strongest topical steroid available.[citation needed] It is also sold with tazarotene with 0.01% halobetasol and 0.045% tazarotene as a lotion branded as Duobrii (Bausch Health).

It is available as a generic medication.[5]

References

  1. [1]
    "Ultravate product monograph" (PDF). Retrieved 2021-01-04.
  2. [2]
    DrugBank DB00596 . Retrieved 2020-01-04.
  3. [3]
    Pearce DJ, Spencer L, Hu J, Balkrishnan R, Fleischer AB, Feldman SR (July 2004). "Class I topical corticosteroid use by psoriasis patients in an academic practice". The Journal of Dermatological Treatment. 15 (4): 235–8. doi:10.1080/09546630410033745. PMID 15764038. S2CID 2757493.
  4. [4]
    ATC code D07AC21 (WHO). Retrieved 2020-01-04.
  5. [5]
    "Ulobetasol international". Drugs.com. 10 August 2020. Retrieved 15 August 2020.
Stub icon

This dermatologic drug article is a stub. You can help Wikipedia by expanding it.
Share this article:

This article uses material from the Wikipedia article Ulobetasol, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.